Related Experiment Video
Updated: Mar 18, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Bleeding Rate After Tooth Extraction in Patients Under Oral Anticoagulant Therapy
Damian Dudek1, Saverio Marchionni, Mario Gabriele
1*Ambulatory Oral Surgery and Implantology, Torun †Department and Clinic of the Histology and Embriology, Zabrze-Rokitnica, Silesian University of Medicine, Katowice, Poland ‡Tuscan Stomatologic Institute, Versilia General Hospital, Lido di Camaiore (LU), Italy §Department of Surgical, Medical, Molecular and Critical Area Pathology, University of Pisa, Pisa ||Free practice in Francavilla Fontana ¶Department of Surgical Sciences, Dental and Maxillofacial Department, University of Verona, Verona, Italy.
Objectives:
The aim of this single-cohort prospective study was to evaluate the risk of adverse outcomes after tooth extraction in patients suffering from cardiovascular disorders and under oral anticoagulant therapy with an international normalized ratio within the value of 3.0.
Methods:
Two hundred ninety-three patients (mean age of 58.7 years) were enrolled and 560 tooth extractions were performed. Fresh extraction sockets were treated with collagen tablets and sutures. The risk of increased bleeding rate was evaluated for type of drug therapy (acenocoumarol or warfarin), type of cardiovascular diseases, and number of tooth extractions. Level of significance was set at 0.05.
Results:
The overall bleeding event rate was 6.8%. Among patients who had bleeding events, 4 suffered from valvular disorders, whereas 11 suffered from arrhythmias (8) or cardiomyopathies (3). The remaining 5 patients had a history of cardiomyopathy and arrhythmia.The bleeding events in patients who had more than 2 tooth extractions were significantly higher than those observed in patients who had only 1 tooth extraction (P <0.05).
Conclusion:
Patients who received more than 2 tooth extractions, who were under treatment with acenocoumarol, and who suffered from multiple cardiovascular diseases were at high risk for bleeding events.
More Related Videos
07:08Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
Published on: September 5, 2017
05:41Author Spotlight: Revealing Platelet Dynamics Through Advances in Structural Hematology
Published on: May 24, 2024
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis IV: Nursing Management
Venous Thrombosis III: Interprofessional Care
Tonsillitis II: Management
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.